<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the specific changes of the secreted protein clusterin and its cytoplasmic precursor regarding colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, using in vitro differentiation of Caco-2 cells </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-like stage, we observed an overexpression of both precursor and secreted clusterin, corroborated in the cell line SW-480 </plain></SENT>
<SENT sid="2" pm="."><plain>Noticeably, SW-620 cells (from a tumoral node, thus with metastatic capacity) did not show overexpression of either precursor or secreted clusterin, suggesting a downregulation related to local <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We further investigated clusterin in serum, finding a significant increase in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients, with 81% sensitivity, 79% specificity, and an area under the ROC curve of 0.85 </plain></SENT>
</text></document>